SRRK
Scholar Rock Holding Corporation
NASDAQ · USHealthcareBiotechnology
$50.66-4.16%
Price as of Jul 20, 2026
SRRK capital
Scholar Rock Holding Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.75x
- Net debt / equity
- -0.81x
- Debt / assets
- 0.38x
- Debt / EBITDA
- -0.51x
- Net debt / EBITDA
- 0.56x
Liquidity & coverage
- Current ratio
- 8.64x
- Quick ratio
- 8.64x
- Cash ratio
- 8.05x
- Interest coverage
- -55.53x
- EBITDA / interest
- -54.20x
- Working capital
- $455.6M
Cash & dividend
- FCF / debt
- -1.48x
- Cash flow / debt
- -1.48x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.